- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0090382

About Anant Pharmaceuticals Private Limited
Data last updated:
Anant Pharmaceuticals Private Limited is a private limited company based in Ambernath, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 February 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2005PTC151401. Its GSTIN is 27AAFCA2392F1ZS (Maharashtra).
The company has an authorised share capital of ₹18 Lakh and a paid-up capital of ₹11.92 Lakh. It is led by directors including Ajit Anil Godbole (Managing Director) and Anupama Ajit Godbole.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. W / 57 A Additional MIDC Anand Nagar, Ambernath, Maharashtra, India – 421507.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.76 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹5.41 Lakh (net margin 0.8%) and EBITDA of ₹94.69 Lakh (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 11% over five years.
The company has about 40 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Anantlabs. As per MCA filings, the company has open charges of ₹5.74 Cr on record.
Anant Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0090382). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anantlabs.com.
Company details
Recognitions & Rankings of Anant Pharmaceuticals
Contact details
Anant Pharmaceuticals Private Limited's registered office is in Ambernath, Maharashtra. Its website is anantlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. W / 57 A Additional MIDC Anand Nagar, Ambernath, Maharashtra, India – 421507
- IndustryPharma, API Manufacturers
To see the full contact details of Anant Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Anant Pharmaceuticals operates one associated brand: Anantlabs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures API impurities and offers custom research and analytical services. | anantlabs.com |
Business activity
The main business activity of Anant Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Anant Pharmaceuticals Private Limited, buy the company report.
Financials of Anant Pharmaceuticals Private Limited
FY 2025 filings availableAnant Pharmaceuticals Private Limited reported revenue of ₹6.76 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 7% growth in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹94.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anant Pharmaceuticals Private Limited, buy the company report.
Board of directors of Anant Pharmaceuticals Private Limited
Anant Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anupama Ajit Godbole | Director | 18 Feb 2005 | 21 Years 8 Months | Current |
| Ajit Anil Godbole | Managing Director | 10 Feb 2010 | 16 Years 8 Months | Current |
| Anil Shankar Godbole | Director | 18 Feb 2005 | 21 Years 8 Months | Current |
Peer comparison
Anant Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gliesse Pharmaceuticals Private Limited | ₹6.78 Cr (FY 2025) | 22.0% | Ahmedabad, Gujarat, India | |||
| Sanora Pharmaceuticals Private Limited | ₹6.77 Cr (FY 2025) | 39.0% | Mumbai, Maharashtra, India | |||
| Anant Pharmaceuticals Private Limitedthis company | ₹6.76 Cr (FY 2025) | ₹5.41 Lakh | 0.8% | 7.0% | 40 | Ambernath, Maharashtra, India |
| Samnova Pharmaceuticals Private Limited | ₹6.74 Cr (FY 2025) | 55.0% | Ahmedabad, Gujarat, India | |||
| HTS Biopharma Private Limited | ₹6.71 Cr (FY 2024) | 7.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Anant Pharmaceuticals Private Limited, buy the company report.
Auditor
Anant Pharmaceuticals Private Limited is audited by K P Mehendale and Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K P Mehendale and Co | FY 2023 | 140086 |
Shareholding
The shareholding of Anant Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Anant Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jul 2025 | 101141716 | Others | ₹25 Lakh | Open | |
| 16 Aug 2024 | 100962099 | Others | ₹59 Lakh | Open | |
| 01 Jan 2024 | 100850260 | Others | ₹25 Lakh | Open | |
| 14 Mar 2023 | 100691972 | Others | ₹25 Lakh | Open | |
| 31 Dec 2022 | 100673067 | Others | ₹30 Lakh | Open |
To see the full charge records of Anant Pharmaceuticals Private Limited, buy the company report.
Total charge records: 10 View all charges
Legal cases
No court or tribunal cases involving Anant Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anant Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Anant Pharmaceuticals Private Limited has a workforce of 40 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Anant Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCA2392F1ZS | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Anant Pharmaceuticals Private Limited, buy the company report.
Recent activity
Anant Pharmaceuticals Private Limited has 6 board changes on record since 2005: 3 appointments and 3 cessations. The latest: Madhavi Anil Godbole ceased to be Director on 24 May 2024.
11 earlier events are in the company report.
Frequently asked questions
Anant Pharmaceuticals is an active private limited company based in Ambernath, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 February 2005 (21+ years old) and is registered under CIN U24100MH2005PTC151401.
Anant Pharmaceuticals has 3 current directors:
- Ajit Anil Godbole - Managing Director
- Anupama Ajit Godbole - Director
- Anil Shankar Godbole - Director
The latest financial statements of Anant Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Anant Pharmaceuticals is 27AAFCA2392F1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Anant Pharmaceuticals is U24100MH2005PTC151401. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anant Pharmaceuticals was incorporated on 18 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Anant Pharmaceuticals by revenue are Gliesse Pharmaceuticals Private Limited, Sanora Pharmaceuticals Private Limited, Samnova Pharmaceuticals Private Limited, HTS Biopharma Private Limited, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Madhavi Anil Godbole ceased to be Director on 24 May 2024. Ajit Anil Godbole ceased to be Director on 29 Sep 2012. Anil Shankar Godbole ceased to be Managing Director on 29 Sep 2012. Anant Pharmaceuticals has 6 board changes on record in total.
Yes, Anant Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0090382).
Anant Pharmaceuticals can be reached through the website anantlabs.com. Its registered office is in Ambernath, Maharashtra, India.
The registered office of Anant Pharmaceuticals is at Plot No. W 57 A Additional MIDC Anand Nagar, Ambernath, Maharashtra, India – 421507.

